APOE4 STATUS AND COGNITIVE FUNCTION IN MIDDLE-AGED AND ELDERLY PEOPLE
Pavel N.A.1, Paun M.R.2, Matei P.V.1,2, Dutu I.1, Tudose C.1,2
*Corresponding Author: Valentin P. Matei, Associate Proffesor, MD, PhD. 2nd Ward of “Prof. Dr. Alexandru Obregia” Hospital, Berceni Street no 10, Bucharest, Romania. E-mail: valipmatei@yahoo.com
page: 6

REFERENCES

1. J. Kim, J. M. Basak, and D. M. Holtzman, “The Role of Apolipoprotein E in Alzheimer’s Disease,” Neuron. 2009; 63(3): 287–303, 2. O. MC, M. SE, Z. G, N. AC, and M. CE, “APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review,” Cortex. 2018; 104: 103–123. 3. G. Jun et al., “Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region,” Arch Neurol. 2012; 69(10): 1270–1279. 4. L. A. Farrer et al., “Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis,” JAMA. 1997; 278(16): 1349–1356. 5. S. M. Laws, E. Hone, S. Gandy, and R. N. Martins, “Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription,” J. Neurochem. 2003; 84(6): 1215–1236. 6. S. Emrani, H. A. Arain, C. DeMarshall, and T. Nuriel, “APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review,” Alzheimers. Res. Ther. 2020; 12(1): 141. 7. R. Cacciaglia et al., “Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease,” Alzheimer’s Dement. 2018; 14(7): 902–912. 8. K. Chen et al., “Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares,” Neuroimage. 2012; 60(4): 2316. 9. A. Montagne et al., “APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline,” Nature. 2020; 581(7806): 71–76. 10. S. Moreno-Grau et al., “Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results,” 2017. 11. World Medical Association, “Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols,” World Med. Assoc. 2013; 1964: 29–32. 12. Diagnostic and statistical manual of mental disorders : DSM-IV. Fourth edition. Washington, DC : American Psychiatric Association, [1994] ©1994. 13. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” J. Psychiatr. Res. 1975; 12(3): 189–198. 14. E. Strauss, E. M. S. Sherman, and O. Spreen, A compendium of neuropsychological tests: Administration, norms, and commentary, 3rd ed. New York, NY, US: Oxford University Press, 2006. 15. A. Rey, “L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.],” Arch. Psychol. (Geneve). 1941; 28: 215–285. 16. Z. Shao, E. Janse, K. Visser, and A. S. Meyer, “What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults,” Front. Psychol. 2014; 5: 1–10. 17. M. D. Lezak, D. B. Howieson, D. W. Loring, and J. S. Fischer, Neuropsychological assessment. Oxford University Press, USA, 2004. 18. L. M. Nichols et al., “Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults,” Arch. Gen. Psychiatry. 2012; 69(8): 804–813. 19. G. A. Rodriguez, M. P. Burns, E. J. Weeber, and G. W. Rebeck, “Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex,” Learn. Mem. 2013; 20(5): 256–266. 20. T. Iachini, A. Iavarone, V. P. Senese, F. Ruotolo, and G. Ruggiero, “Visuospatial Memory in Healthy Elderly, AD and MCI: A Review,” Curr. Aging Sci. 2009; 2: 43–59. 21. R. J. Piers, Y. Liu, T. F. A. Ang, Q. Tao, R. Au, and W. Q. Qiu, “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study,” J. Alzheimer’s Dis. 2021; 80(3): 1269–1279. 22. F. Mashayekhi, S. Sadigh-Eteghad, A. Naseri, M. Asadi, N. A. Garravnd, and M. Talebi, “ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study,” Neurol. Sci. 2021. 2021; 1–8. 23. I. Reinvang, T. Espeseth, and L. T. Westlye, “APOErelated biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease,” Neurosci. Biobehav. Rev. 2013; 37: 1322–1335.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006